Cold, Flu and Allergy Remedies - US - October 2007

Table of Contents

• Scope and ThemesWhat you need to know
• Definition
• Consumer research methodology
• Abbreviations and terms
• Abbreviations
• Terms
• Executive Summary
• Sales driven by incidence, population factors
• A healthy market boosted by Rx switches and new product launches
• Tablets lead market as liquids slip and nasal products gain ground
• Mergers consolidate supply structure
• Ad & promo
• Professional staff drive sales to drug channel--even for common cold and allergy remedies
• The consumer
• Incidence of ailments and usage of remedies
• Attitudes towards CF&A remedies
• The ethnic consumer
• What the future holds
• Market Drivers
• Incidence of cold, flu, and allergies
• Key points
• Details
  • Figure 1: Severity of flu (only), October 2006
  • Figure 2: Severity of nasal allergies/hay fever (only), October 2006
• Seasonal severity
  • Figure 3: Influenza seasonal severity, in the U.S., 2000-06
• Higher contraction risk among children, women, elderly
  • Figure 4: Population by age, 2002-12
  • Figure 5: Population of OTC flu remedy users, based on those confirmed to have the flu, by gender, 2002-12
• Rx switches boost sales
• Uninsured turn to self-care, diagnosis
• Shift of pseudoephedrine to behind the counter
• Alternative remedies cut into OTC sales
• Vaccines and Rx remedies compete with OTC
  • Figure 6: Preference for OTC vs. Rx cold, flu, and allergy remedies, October 2006
• Market Size and Trends
• Market size
  • Figure 7: Total U.S. retail sales of cold, flu, and allergy remedies, at current and constant prices, 2002-07
• Wal-Mart estimate
• Market trends
• Multi-symptom relief
• Flavor
• Natural/organic ingredients
• Market Segmentation
• Cold, flu, and allergy remedy segments
  • Figure 8: FDM sales of cold, flu, and allergy remedies, segmented by delivery form, 2005 and 2007
• Tablets
  • Figure 9: Sales of cold, flu, and allergy remedy tablets, at current and constant prices, 2002-07
• Liquids
  • Figure 10: Sales of cold, flu, and allergy remedy liquids, at current and constant prices, 2002-07
• Nasal products
  • Figure 11: Sales of cold, flu, and allergy remedy nasal products, at current and constant prices, 2002-07
• Supply Structure
• Introduction
• Companies and brands
  • Figure 12: Manufacturer FDM sales of cold, flu, and allergy remedies in the U.S., 2005 and 2007
• Tablets
  • Figure 13: Manufacturer brand sales of cold, flu, and allergy remedy tablets, in the U.S., 2005 and 2007
• Liquids
  • Figure 14: Manufacturer brand sales of cold, flu, and allergy remedy liquids, in the U.S., 2005 and 2007
• Nasal products
  • Figure 15: Manufacturer brand sales of cold, flu, and allergy remedy nasal products, in the U.S., 2005 and 2007
• Advertising and Promotion
• Introduction
  • Figure 16: Promotional expenditures of the top CF&A manufacturers*, 2005-06
• Television marketing campaigns
• Schering-Plough
  • Figure 17: Corocidin TV spot--high blood pressure-safe
• Pfizer, Inc.
  • Figure 18: PediaCare liquid TV spot--pediatrician-endorsed
  • Figure 19: Sudacare Shower Soother and Sudacare Vapor Plug TV spot--non-medicated
  • Figure 20: Sudacare Shower Soother TV spot--non-medicated
• Procter & Gamble
  • Figure 21: Vicks NyQuil and Vicks DayQuil TV spot--fast relief
  • Figure 22: Vicks NyQuil TV spot--tried and true
• McNeil
  • Figure 23: Children' s Motrin liquid TV spot--pediatrician-endorsed
  • Figure 24: Tylenol Cold Multi-Symptom TV spot--multi-symptom; comparative advertising
  • Figure 25: Children' s Tylenol Plus Cold TV spot--multi-symptom; doctor-recommended
• Adams Respiratory Therapeutics
  • Figure 26: Mucinex DM TV spot--memorable character
• Wyeth Labs, Inc.
  • Figure 27: Advil TV spot--multi-symptom relief
  • Figure 28: Robitussin TV spot--wide product range
• Novartis
  • Figure 29: TheraFlu Warming relief TV spot--restorative
  • Figure 30: Triaminic Nighttime Cold & Cough TV spot--child-friendly advertising
• Other companies
  • Figure 31: Zicam TV spot--consumer testimonial
  • Figure 32: Zicam Cough Max TV spot--convenience
  • Figure 33: Alka-Seltzer Plus liquid TV spot--multi-symptom relief
  • Figure 34: Aleve cold/sinus TV spot--"real people;" circumvents pseudoephedrine restrictions
• Retail Distribution
• Introduction
  • Figure 35: U.S. FDM and convenience store retail sales of cold, flu, and allergy remedies, by channel, 2005 and 2007
• Drug stores
  • Figure 36: U.S. drug store sales of cold, flu, and allergy remedies, at current and constant prices, 2002-07
• Supermarkets
  • Figure 37: U.S. supermarket sales of cold, flu, and allergy remedies, at current and constant prices, 2002-07
• Mass merchandisers
  • Figure 38: U.S. mass merchandiser sales of cold, flu, and allergy remedies, at current and constant prices, 2002-07
• Convenience stores
  • Figure 39: U.S. convenience store sales of cold, flu, and allergy remedies, at current and constant prices, 2002-07
• The Consumer: Use of Cold, Flu, and Allergy Remedies
• Summary
• Incidence of ailments, usage of remedies
• Incidence of flu and allergies
  • Figure 40: Incidence of flu and nasal allergies/hay fever, by age, January-October 2006
• Severity of flu and nasal allergies/hay fever
  • Figure 41: Severity of flu and nasal allergies/hay fever, by age, January-October 2006
• Use of cold, flu, and sinus remedies
  • Figure 42: Use of cold, flu, and allergy remedies, by age, January-October 2006
• Preferred brands of cold, flu, and allergy remedies
  • Figure 43: Preferred brands of cold, flu, and allergy remedies, by age, January-October 2006
• Frequency of usage of cold, flu, and allergy remedies
  • Figure 44: Frequency of usage of cold, flu, and allergy remedies, by age, January-October 2006
• OTC vs. Rx cold, flu, and allergy remedies
  • Figure 45: Preference for OTC vs. Rx cold, flu, and allergy remedies, by age, January-October 2006
• Ailments treated with cold, flu, and allergy remedies
  • Figure 46: Ailments treated with cold, flu, and allergy remedies, by age, January-October 2006
• Household usage of children' s cold, flu, and allergy remedies
  • Figure 47: Household usage of children' s cold, flu, and allergy remedies, January-October 2006
• Types and brands of children' s remedies preferred among households
  • Figure 48: Household preference for types and brands of children' s cold, flu, and allergy remedies, January-October 2006
• Teen use of cold, flu, and allergy remedies
  • Figure 49: Teen use of cold, flu, and allergy remedies, by gender and age, January-October 2006
• The Consumer: Attitudes towards Cold, Flu, and Allergy Remedies and Their Side Effects
• Summary
• Attitudes towards cold, flu, and allergy remedies
  • Figure 50: Attitudes towards cold, flu, and allergy remedies, by gender, August 2007
  • Figure 51: Attitudes towards cold, flu, and allergy remedies, by age, August 2007
  • Figure 52: Attitudes towards cold, flu, and allergy remedies, by number of children in household, August 2007
• Side effects from cold, flu, allergy remedies
  • Figure 53: cold, flu, and allergy remedy side effects experienced in the past 12 months, by age, August 2007
• The Consumer: Ethnic Use of Cold, Flu, and Allergy Remedies
• Summary
• Incidence of ailments, usage of remedies among ethnicities
• Incidence of flu and allergies among ethnicities
  • Figure 54: Incidence of flu and nasal allergies/hay fever, by race/ethnicity, January-October 2006
• Severity of flu and nasal allergies/hay fever among ethnicities
  • Figure 55: Severity of flu and nasal allergies/hay fever, by race/ethnicity, January-October 2006
• Preferred formulations of cold, flu, and allergy remedies among ethnicities
  • Figure 56: Preference for 4-6-hour or 12-hour cold, flu, and allergy remedies, by race/ethnicity, January-October 2006
• Preferred brands of cold, flu, and allergy remedies among ethnicities
  • Figure 57: Preferred brands of cold, flu, and allergy remedies, by race/ethnicity, January-October 2006
• Frequency of usage of cold, flu, and allergy remedies among ethnicities
  • Figure 58: Frequency of usage of cold, flu, and allergy remedies, by race/ethnicity, January-October 2006
• OTC vs. Rx cold, flu, and allergy remedies preferences among ethnicities
  • Figure 59: Preference for OTC vs. Rx cold, flu, and allergy remedies, by race/ethnicity, January-October 2006
• Ailments ethnicities treat with cold, flu, and allergy remedies
  • Figure 60: Ailments treated with cold, flu, and allergy remedies, by race/ethnicity, January-October 2006
• Attitudes towards cold, flu, and allergy remedies among ethnicities
  • Figure 61: Attitudes towards cold, flu, and allergy remedies, by race/ethnicity, August 2007
• Side effects from cold, flu, allergy remedies experienced among ethnicities
  • Figure 62: cold, flu, and allergy remedy side effects experienced in the past 12 months, by race/ethnicity, August 2007
• Future and Forecast
• Future trends
• OTC switch of Zyrtec promises market boost
• FDA advisory panel advises against children' s cough and cold remedies; manufacturers pull infants' remedies
• Market forecast
• Cold, flu, and allergy remedies
  • Figure 63: Forecast of total U.S. retail sales of cold, flu, and allergy remedies, at current and constant prices, 2007-12
• Cold, flu, and allergy remedy tablets
  • Figure 64: Forecast of U.S. FDM sales of cold, flu, and allergy remedy tablets, at current and constant prices, 2007-12
• Cold, flu, and allergy remedy liquids
  • Figure 65: Forecast of U.S. FDM sales of cold, flu, and allergy remedy liquids, at current and constant prices, 2007-12
• Cold, flu, and allergy remedy nasal products
  • Figure 66: Forecast of U.S. FDM sales of cold, flu, and allergy remedy nasal products, at current and constant prices, 2007-12
• Forecast factors
• Appendix: Trade Associations